Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.


Previous Article Next Article

Today in Regulatory Issues...keeping you current

Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09

Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09

Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address